 |
|
|
 |
FDA allows qualified health claim linking walnuts and reduced risk of heart disease
The Food and Drug Administration today announced that a qualified health claim will soon appear on product labels for walnuts and the reduced risk of coronary heart disease. This qualified health claim is part of the FDA’s initiative to provide Americans with better information to help them make healthier dietary choices.
more
|
|
NIAID vaccine protects against SARS virus infection in mice
An experimental vaccine prevents the SARS virus from replicating
in laboratory mice, according to a new report in the April 1 issue
of Nature. Scientists at the Vaccine Research Center (VRC) of the
National Institute of Allergy and Infectious Diseases (NIAID), one
of the National Institutes of Health, developed the vaccine. The
vaccine was tested in a mouse model of SARS infection recently validated
by other NIAID investigators. more
|
|
Autism gene found
Researchers at Mount Sinai School of Medicine are first to strongly link a specific gene with autism. While earlier studies have found rare genetic mutations in single families, a study published in the April issue of the American Journal of Psychiatry is the first to identify a gene that increases susceptibility to autism in a broad population. more
|
|
|
|
Schizophrenia patients don’t take medications regularly
Despite improved drugs for schizophrenia – a devastating mental illness that affects more than 2 million Americans and one percent of the world's population – a new study shows that only 41 percent of patients take their antipsychotic medication on a regular basis. Researchers also found that out-patient and hospital medical costs are significantly higher in the patients who are not regularly adherent to a prescribed drug regimen.
more
|
|
Research questions method used to remove virus from bones and tissue used for transplants
A method once thought to inactivate retroviruses such as HIV from bones and connective tissues used in transplant procedures may not be quite as effective as originally thought, researchers at Michigan State University have concluded. more
|
|
Mayo Clinic researchers discover green tea component helps kill leukemia cells
Mayo Clinic researchers have discovered that a component in green tea helps kill cells of the most common leukemia in the United States. The research using laboratory cell cultures shows that a component of green tea known as epigallocatechin-3-gallate (EGCG) [epi-gallo-cat-ekin-3-gal-ate] helps kill leukemia cells by interrupting the communication signals they need to survive. more
|
|
Advanced SCLC can tolerate and benefit from the chemotherapy drug topotecan
Oncologists face extremely difficult decisions when treating patients with advanced small-cell lung cancer (SCLC), a less common but more aggressive form of cancer. Typically, treatment for SCLC entails chemotherapy or radiation. But when the disease is advanced or recurring, patients often are in poor health overall and are less equipped to handle the toxicity and devastation of powerful cancer treatments. more
|
|
|
